Last reviewed · How we verify
NCT05251584
Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection
NA trial testing Mupirocin in Peritoneal Dialysis-related Infection in 60 participants. Status unknown.
31 March 2023
Quick facts
| Lead sponsor | Phramongkutklao College of Medicine and Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 December 2021 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Mupirocin (MUPIROCIN) — full drug profile →
- Gentamicin (GENTAMICIN) — full drug profile →
Conditions studied
- Peritoneal Dialysis-related Infection — all drugs for Peritoneal Dialysis-related Infection →
Sponsor
Phramongkutklao College of Medicine and Hospital
Who can join
20 and older, any sex, with Peritoneal Dialysis-related Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis catheter removal or patient death. The present study aimed to investigate peritoneal dialysis-related infection, causative pathogens resulting in topical 2% mupirocin ointments period compare with 0.1% gentamicin cream period. Rate of catheter removal, time to first peritoneal dialysis-related infection after apply gentamicin cream.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05251584
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mupirocin
Trials testing the same drug.
- NCT03673956 — Topical Antibiotics in Chronic Rhinosinusitis · Phase 1, PHASE2 · completed
- NCT03489629 — STaph Aureus Resistance-Treat Early and Repeat (STAR-TER) · Phase 2 · completed
- NCT03173053 — S. Aureus Decolonization in HPN Patients. · NA · terminated
- NCT02216227 — Checklist to Prevent MRSA Surgical Site Infections · NA · completed
- NCT01269541 — MESS-study MRSA Eradication Study Skåne · NA · completed
Other Phramongkutklao College of Medicine and Hospital trials
Trials by the same sponsor.
- NCT07366450 — High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma · NA · not yet recruiting
- NCT07014371 — Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA) · NA · recruiting
- NCT06491342 — Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease · NA · completed
- NCT06279507 — Efficacy of Hyaluronic Acid Injection in Knee Osteoarthritis · Phase 4 · unknown
- NCT06049771 — The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carba · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05251584 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Phramongkutklao College of Medicine and Hospital
- Last refreshed: 22 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05251584.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing